Compugen (CGEN)

Compugen (CGEN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $219M; returns 1 day -1.0%, 1 week -1.0%, 1 year +16.2%.

Compugen Ltd. (CGEN) is a clinical-stage therapeutic discovery and development company based in Israel, focused on cancer immunotherapy. The company leverages its proprietary predictive AI/Machine Learning-powered computational discovery platform, Unigen™, to identify novel drug targets and biological pathways for the development of new cancer therapies.

Groups CGEN belongs to

• Clinical Stage Biotech
• Israel Companies
• Biotechnology
• Oncology
• Biopharmaceutical
• Immunotherapy
• Artificial Intelligence
• Drug Discovery
• Israel
• Clinical Stage
• Monoclonal Antibodies

CGEN financial model: income statement, cash flow and balance sheet